A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults

Karpf, DB; Pihl, S; Mourya, S; Mortensen, E; Kovoor, E; Markova, D; Leff, JA

Karpf, DB (corresponding author), Ascendis Pharma Inc, 500 Emerson St, Palo Alto, CA 94301 USA.

JOURNAL OF BONE AND MINERAL RESEARCH, 2020; 35 (8): 1430

Abstract

TransCon PTH is a sustained-release, essentially inactive prodrug transiently bound to an inert carrier, designed to release PTH(1-34), and in develop......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索